Skip to main content
. 2022 Sep 18;14(9):645. doi: 10.3390/toxins14090645

Figure 3.

Figure 3

Depiction of future experimental perspectives. The use of biotics represents an important therapeutic target to achieve eubiosis and reduce intestinal inflammation, either through the promotion of the synthesis of beneficial indole metabolites or through the enhanced synthesis of SCFAs. A decrease in the levels of deleterious metabolites such as indoxyl sulfate is warranted for the reduction of intestinal homeostasis.